Kevin Joseph Fitzgerald, CSO & EVP, Head of Research: Alnylam Pharmaceuticals ALNY Sell · Filed 25/11/19

Trade details

Type: Insider sale
Amount: $3,667,432
Shares · price: 8,168 sh · $449.00 a share
Held after: 25,224 sh
Stock: Alnylam Pharmaceuticals ALNY
Person: Kevin Joseph FitzgeraldCSO & EVP, Head of Research
Trade date: 25/11/17
Filed: 25/11/19
Days to filing: 2 days

Sold 24.5% of holdings

Share of holding sold: 24.5%

Alnylam Pharmaceuticals trades, last 26 weeks

What else happened in Alnylam Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/10/18~25/12/17

Kevin Joseph Fitzgerald's recent trades

Kevin Joseph FitzgeraldCSO & EVP, Head of Research
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$75.3K
233 sh
$75.3K
Filed 03/06
Traded 03/05
Kevin Joseph FitzgeraldCSO & EVP, Head of Research
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$68K
210 sh
$68K
Filed 03/06
Traded 03/04
Kevin Joseph FitzgeraldCSO & EVP, Head of Research
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$49.9K
153 sh
$49.9K
Filed 03/06
Traded 03/05
Kevin Joseph FitzgeraldCSO & EVP, Head of Research
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$48K
148 sh
$48K
Filed 03/06
Traded 03/05
Kevin Joseph FitzgeraldCSO & EVP, Head of Research
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$39.9K
124 sh
$39.9K
Filed 03/06
Traded 03/05